Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation

Abstract

Hepatic veno-occlusive disease (VOD) is one of the most serious complications in patients receiving stem cell transplantation (SCT). However, the cause of VOD remained to be elucidated. Vascular endothelial growth factor (VEGF) has been reported to have various physiological effects including neovascularization and acceleration of vasopermeability. Because we postulated that VEGF could be one of the causative factors in VOD after SCT, serum VEGF levels were measured by ELISA in 50 patients receiving SCT. Six of the patients showed typical manifestations of VOD and four of them died due to VOD. The mean maximum serum VEGF level in the six patients with VOD was markedly increased compared to that in the patients without VOD (P < 0.001) and in normal controls (P < 0.001). Moreover, the mean maximum serum VEGF level in patients with VOD before conditioning chemoradiotherapy for SCT was also high compared to patients without VOD (P = 0.0012) in the same period. Similarly, serum VEGF levels were significantly higher in patients whose plasma protein C activities decreased below 40% (P < 0.001). during the clinical course of VOD after SCT, the increase of serum VEGF synchronized fairly well with the development of VOD. Since VEGF causes the expression of tissue factor on circulating monocyte/ macrophages and results in hypercoagulability, our observation suggests that in the patients with VOD who showed high serum VEGF it might account for the development of VOD. Furthermore, this observation may indicate a novel therapeutic strategy for prevention of VOD. Bone Marrow Transplantation (2001) 27, 1173–1180.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. McDonald GB, Sharma P, Matthews DE et al. Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors Hepatology 1984 4: 116–122

    Article  CAS  Google Scholar 

  2. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 118: 255–267

    Article  CAS  Google Scholar 

  3. Harper PL, Jarvis J, Jennings I et al. Changes in natural anticoagulants following bone marrow transplantation Bone Marrow Transplant 1990 5: 39–42

    CAS  PubMed  Google Scholar 

  4. Scrobohaci ML, Drouet L, Monem-Mansi A et al. Liver veno-occulusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers Thromb Res 1991 63: 509–519

    Article  CAS  Google Scholar 

  5. Faioni EM, Krachmalnicoff A, Bearman SI et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver Blood 1993 81: 3458–3462

    CAS  Google Scholar 

  6. Tanaka J, Imamura M, Kasai M et al. Rapid analysis of tumor necrosis factor-alpha mRNA expression during venocclusive disease of the liver after allogeneic bone marrow transplantation Transplantation 1993 55: 430–432

    Article  CAS  Google Scholar 

  7. Gugliotta L, Catani L, Vianelli N et al. High plasma levels of tumor necrosis factor-α may be predictive of veno-occlusive disease in bone marrow transplantation Blood 1994 83: 2385–2386

    CAS  Google Scholar 

  8. Murase T, Anscher MS, Petros WP et al. Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity Bone Marrow Transplant 1995 15: 173–178

    CAS  PubMed  Google Scholar 

  9. Ferrara N, Houck KA, Jakeman LB et al. The vascular endothelial growth factor family of polypeptides J Cell Biochem 1991 47: 211–218

    Article  CAS  Google Scholar 

  10. Leung DW, Cachianes G, Kuang W-J et al. Vascular endothelial growth factor is a secreted angiogenic mitogen Science 1989 246: 1306–1309

    Article  CAS  Google Scholar 

  11. Conn G, Soderman D, Schaffer M-T et al. Purification of a glycoprotein vascular endothelial mitogen from a rat glioma cell line Proc Natl Acad Sci USA 1990 87: 1323–1327

    Article  CAS  Google Scholar 

  12. Connolly DT, Heuvelmann DM, Nelson R . Tumor vascular permeability factor stimulates endothelial growth and angiogenesis J Clin Invest 1989 84: 1470–1478

    Article  CAS  Google Scholar 

  13. Ferrara N, Houck KA, Jakeman LB, Leung DW . Molecular and biological properties of the vascular endothelial growth factor family of proteins Endocr Rev 1992 13: 18–32

    Article  CAS  Google Scholar 

  14. Storb R, Deeg HJ, Farewell V et al. Marrow transplantation for severe aplastic anemia: methotrexate and cyclosporine for prevention of acute graft-versus-host disease Blood 1986 68: 119–125

    CAS  Google Scholar 

  15. Glucksberg H, Storb R, Fefer A et al. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304

    Article  CAS  Google Scholar 

  16. Hanatani M, Tanaka Y, Kondo S et al. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum Biosci Biotech Biochem 1995 59: 1958–1959

    Article  CAS  Google Scholar 

  17. Watanabe O, Arimura K, Kitajima I et al. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome Lancet 1996 347: 702

    Article  CAS  Google Scholar 

  18. Clauss M, Grell M, Fangmann C et al. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: functional analysis of the tumor necrosis factor receptors FEBS Lett 1996 390: 334–338

    Article  CAS  Google Scholar 

  19. Zucker S, Mirza H, Conner CE et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation Int J Cancer 1998 75: 780–786

    Article  CAS  Google Scholar 

  20. Armesilla A L, Lorenzo E, Gomez del Arco P et al. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression Mol Cell Biol 1999 19: 2032–2043

    Article  Google Scholar 

  21. Taichman NS, Young S, Cruchley AT et al. Human neutrophils secrete vascular endothelial growth factor J Leukoc Biol 1997 62: 397–400

    Article  CAS  Google Scholar 

  22. Gaudry M, Bregerie O, Andrieu V et al. Intracellular pool of vascular endothelial growth factor in human neutrophils Blood 1997 90: 4153–4163

    CAS  PubMed  Google Scholar 

  23. Webb NJ, Myers CR, Watson CJ et al. Activated human neutrophils express vascular endothelial growth factor (VEGF) Cytokine 1998 10: 254–257

    Article  CAS  Google Scholar 

  24. Iguchi A, Kobayashi R, Yoshida M et al. Neurological complications after stem cell transplantation in childhood Bone Marrow Transplant 1999 24: 647–652

    Article  CAS  Google Scholar 

  25. Mochida S, Arai M, Ohno A, Fujiwara K . Bacterial translocation from gut to portal blood as a factor of hypercoagulopathy in hepatic sinusoids after orthotopic liver transplantation in rats Transplant Proc 1997 29: 874–875

    Article  CAS  Google Scholar 

  26. Mochida S, Arai M, Ohno A et al. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats Hepatology 1999 29: 1532–1540

    Article  CAS  Google Scholar 

  27. Matsushita K, Motani R, Sakuta T et al. Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture Infect Immun 1999 67: 1633–1639

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Mochida S, Ishikawa K, Toshima K et al. The mechanisms of hepatic sinusoidal cell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells J Gastroenterol Hepatol 1998 13: (Suppl.) S1–5

    Article  CAS  Google Scholar 

  29. Cooke KR, Hill GR, Crawford JM et al. Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease J Clin Invest 1998 102: 1882–1891

    Article  CAS  Google Scholar 

  30. Li W, Keller G . VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells J Cell Sci 2000 113: 1525–1534

    CAS  PubMed  Google Scholar 

  31. Calnek DS, Grinnell BW . Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor Exp Cell Res 1998 238: 294–298

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Mrs Mieko Inamura and Mrs Noriko Yoshihara for their excellent technical assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iguchi, A., Kobayashi, R., Yoshida, M. et al. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation. Bone Marrow Transplant 27, 1173–1180 (2001). https://doi.org/10.1038/sj.bmt.1703061

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703061

Keywords

This article is cited by

Search

Quick links